- Home
- ALDX vs NUS Comparison
ALDX vs NUS Comparison
Compare ALDX & NUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- NUS
- Stock Information
- Founded
- ALDX 2004
- NUS 1984
- Country
- ALDX United States
- NUS United States
- Employees
- ALDX N/A
- NUS N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- NUS Other Pharmaceuticals
- Sector
- ALDX Health Care
- NUS Health Care
- Exchange
- ALDX Nasdaq
- NUS Nasdaq
- Market Cap
- ALDX 304.9M
- NUS 353.9M
- IPO Year
- ALDX 2014
- NUS 1996
- Fundamental
- Price
- ALDX $5.40
- NUS $6.92
- Analyst Decision
- ALDX Strong Buy
- NUS Hold
- Analyst Count
- ALDX 2
- NUS 2
- Target Price
- ALDX $10.00
- NUS $6.88
- AVG Volume (30 Days)
- ALDX 394.0K
- NUS 743.8K
- Earning Date
- ALDX 03-06-2025
- NUS 02-13-2025
- Dividend Yield
- ALDX N/A
- NUS 3.41%
- EPS Growth
- ALDX N/A
- NUS N/A
- EPS
- ALDX N/A
- NUS N/A
- Revenue
- ALDX N/A
- NUS $1,775,172,000.00
- Revenue This Year
- ALDX N/A
- NUS N/A
- Revenue Next Year
- ALDX N/A
- NUS N/A
- P/E Ratio
- ALDX N/A
- NUS N/A
- Revenue Growth
- ALDX N/A
- NUS N/A
- 52 Week Low
- ALDX $2.71
- NUS $5.95
- 52 Week High
- ALDX $6.55
- NUS $18.97
- Technical
- Relative Strength Index (RSI)
- ALDX 60.04
- NUS 48.90
- Support Level
- ALDX $4.95
- NUS $6.71
- Resistance Level
- ALDX $5.10
- NUS $7.21
- Average True Range (ATR)
- ALDX 0.24
- NUS 0.34
- MACD
- ALDX 0.04
- NUS 0.01
- Stochastic Oscillator
- ALDX 85.06
- NUS 60.50
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.
About NUS Nu Skin Enterprises Inc.
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.